8th International Congress on Pharmaceutical Chemistry, Active Ingredient Design, Synthesis, Production and Standardization.
We participated in the 8th International Pharmaceutical Chemistry Congress with presentations on active ingredient design, synthesis, and production standardization.
The 8th International Pharmaceutical Chemistry Congress brought together international experts in active ingredient design, synthesis, production, and standardisation.
The Vefa İlaç R&D team participated actively with both session chair roles and paper presentations.
Related News
As Vefa İlaç & VeNatura, we attended the 2nd Congress of the Federation of Women’s Health Associations on 22–26 April 2026.
We attended the 2nd Congress of the Federation of Women’s Health Associations.
We ranked 21st among the top 50 companies by number of trademarks obtained under Turkishtime R&D 250.
In the Turkishtime R&D 250 research, we ranked 21st among the top 50 companies by trademark registrations — an important marker of our R&D and innovation investments.
Our poster prepared by our R&D Center won an award at the 10th International Pharmaceutical Chemistry Congress.
At the 10th International Pharmaceutical Chemistry Congress, the poster presented by our R&D Center was recognised by the scientific jury.